Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma - Busse, W W; Holgate, S; Kerwin, E; Chon, Y; Feng, J; Lin, J; Lin, S L (Am J Respir Crit Care Med, 2013)